FDA spanks Sanofi vaccine plant for violations

The FDA took Sanofi ($SNY) to task for manufacturing flaws at two vaccine manufacturing plants, in a warning letter posted yesterday. The missive details more than two dozen shortfalls, and requests a meeting with global vaccines chief Olivier Charmeil to discuss his plans for fixes. Report